Shin H J, Sneige N, Staerkel G A
Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Cancer. 1999 Jun 25;87(3):149-54. doi: 10.1002/(sici)1097-0142(19990625)87:3<149::aid-cncr8>3.0.co;2-1.
Fine-needle aspiration (FNA) is a fast, reliable, and cost-efficient technique for diagnosing palpable masses. However, when the lesion is small, dermal in location, shallow in depth, or fibrotic, the cellular yield by FNA may be limited and thus hinder an accurate diagnosis. The authors examined the value of punch biopsy (PB) in diagnosing such hard-to-aspirate lesions.
The authors reviewed 49 PB specimens from 47 patients who presented in their FNA clinic from June 1994 to July 1997.
The lesions were typically described as ill-defined erythematous skin lesions or as papules or small, firm, subcutaneous nodules (average size, 0.7 cm). Patients' previous history included breast carcinoma (in 36 cases), nonmammary carcinoma (in 3 cases), melanoma (in 2 cases), squamous carcinoma of the skin (in 2 cases), cutaneous T-cell lymphoma (in 2 cases), small lymphocytic lymphoma (in 1 case), and no history of malignancy (in 1 case). PB sites included chest wall, breast, extremities, abdominal wall, neck, back, scalp, and forehead. Of the 37 cases in which FNA was performed before PB, 21 aspirates (57%) were nondiagnostic because of scant cellularity, 11 aspirates (31%) were positive (9) or suspicious/atypical (2) for malignancy, and 5 aspirates (14%) were negative for malignancy. Seventeen (81%) of the 21 nondiagnostic aspirates and 10 of the 11 suspicious/atypical aspirates were positive for malignancy on PB specimens. Twelve PBs were done without prior FNA, 8 (67%) were positive for malignancy, and 4 (33%) were negative. In 7 patients, the findings from the PB specimens (new diagnosis of malignancy in 5 cases and recurrence of disease in 2 cases) led to surgical excision of the lesion.
PB is a valuable adjunct to FNA for diagnosing hard-to-aspirate lesions.
细针穿刺抽吸活检(FNA)是一种快速、可靠且经济高效的可触及肿块诊断技术。然而,当病变较小、位于真皮层、深度较浅或纤维化时,FNA的细胞获取量可能有限,从而阻碍准确诊断。作者研究了钻孔活检(PB)在诊断此类难以穿刺的病变中的价值。
作者回顾了1994年6月至1997年7月在其FNA门诊就诊的47例患者的49份PB标本。
病变通常表现为边界不清的红斑性皮肤病变或丘疹或小而硬的皮下结节(平均大小0.7厘米)。患者既往病史包括乳腺癌(36例)、非乳腺癌(3例)、黑色素瘤(2例)、皮肤鳞状细胞癌(2例)、皮肤T细胞淋巴瘤(2例)、小淋巴细胞淋巴瘤(1例)以及无恶性肿瘤病史(1例)。PB部位包括胸壁、乳房、四肢、腹壁、颈部、背部、头皮和前额。在PB前进行FNA的37例病例中,21例抽吸物(57%)因细胞数量少而无法诊断,11例抽吸物(31%)对恶性肿瘤呈阳性(9例)或可疑/非典型(2例),5例抽吸物(14%)对恶性肿瘤呈阴性。21例无法诊断的抽吸物中有17例(81%)和11例可疑/非典型抽吸物中有10例在PB标本上对恶性肿瘤呈阳性。12例PB在未进行FNA的情况下进行,8例(67%)对恶性肿瘤呈阳性,4例(33%)呈阴性。在7例患者中,PB标本的结果(5例新诊断为恶性肿瘤,2例疾病复发)导致病变的手术切除。
PB是FNA诊断难以穿刺病变的有价值辅助手段。